Deciphering molecular mechanisms controlling age-associated uterine adaptabilityto pregnancy

破译控制与年龄相关的子宫妊娠适应性的分子机制

基本信息

  • 批准号:
    10636576
  • 负责人:
  • 金额:
    $ 56.04万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-04-01 至 2028-01-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY Advanced maternal age (i.e., ≥35 years old) is considered a major risk factor for birth defects. In women over 40 years of age, the incidence of spontaneous abortion can increase to >30%. Much attention has been focused on ovarian function and oocyte quality, but we provide evidence that uterine decidualization defects could be a major cause of age-related reproductive decline. This problem is likely due to a blunted progesterone (P4) responsiveness of the aging uterus, via its cognate nuclear receptor PGR. PGR is the master regulator for the establishment and maintenance of pregnancy; however, a significant diminution in PGR results in a blunted hormonal response as the uterus ages. The underlying molecular mechanisms that diminish expression of PGR and deregulate PGR target genes likely account for uterine aging, a mechanism that has remained elusive. Our recent discovery of uterine Sirtuin 1 (SIRT1) as a critical driver of age-related PGR action by which endometrial stromal cells decidualize impacts our knowledge of uterine biology and reproductive aging. By deleting uterine SIRT1 in mice, we generated a genetic model (PgrCre/+Sirt1f/f, i.e. Sirt1d/d) for research on premature uterine aging due to blunted PGR response that are similar to those associated with physiologic aging. Thus, this study will be the first attempt to use physiological (46-54 weeks of age) and genetic (Sirt1-deficient) aging mouse models to discover a novel uterine perspective of mammalian reproductive aging. This proposal will provide the first molecular characterization of implantation and decidualization in the context of premature uterine aging (genetic aging; Sirt1d/d) by all-in-one multimodal single-cell ATAC-seq/RNA-seq and comparative analyses with physiologic aging, identifying common gene signatures, cis-regulatory elements and transcriptional co-factors in endometrial cells required for establishment and maintenance of pregnancy but susceptible to reproductive aging. We will also translate the findings in mice to human biology using hTERT-immortalized human endometrial stromal cells (T-HESCs) as decidualization of stromal cells are major defects during physiological and genetic aging. Combined with multimodal single cell datasets between human and mouse models, as well as functional validation of candidate cis-regulatory elements and transcriptional co-factors by CRISPR deletion and activation systems, respectively, this proposal will delineate SIRT1-responsive regulatory network required for PGR actions that deregulate as uterus ages. We strongly believe that our study will give a deeper and more comprehensive insight into progesterone-resistant endometrium during reproductive aging. With that new knowledge, research can pursue strategies to counteract adverse effects of aging on outcomes of pregnancy.
项目摘要 高级母校年龄(即≥35岁)被认为是先天缺陷的主要危险因素。在40岁以上的女性中 年龄,赞助的赞助事件可能会增加到> 30%。非常关注 卵巢功能和卵母细胞质量,但我们提供了子宫决策缺陷的证据可能是 与年龄相关的生殖下降的主要原因。这个问题可能是由于孕酮钝(P4)引起的 衰老子宫的反应性,通过其同源核受体PGR。 PGR是主调节器 妊娠的建立和维持;但是,PGR的显着维度导致钝化 激素反应作为子宫年龄。降低PGR表达的基本分子机制 放松管制PGR靶基因可能解释了子宫衰老,这种机制仍然难以捉摸。我们的 最近发现子宫sirtuin 1(SIRT1)是与年龄相关的PGR动作的关键驱动力 基质细胞决定对我们对子宫生物学和生殖衰老的了解。通过删除子宫 SIRT1在小鼠中,我们生成了一种遗传模型(PGRCRE/+SIRT1F/F,即SIRT1D/D),用于对子宫的早熟研究 由于PGR反应钝,与生理衰老相似。那将是 首次尝试使用物理(46-54周龄)和遗传(缺乏SIRT1缺陷)老鼠模型的尝试 发现哺乳动物生殖衰老的新子宫观点。该建议将提供第一个 植入和决策的分子表征在过早的子宫衰老(遗传)的背景下 老化; SIRT1D/d)通过多模式的单模式单细胞ATAC-SEQ/RNA-SEQ和比较分析 生理衰老,鉴定常见基因特征,顺式调节元素和转录副因素 建立和维持怀孕所需的子宫内膜细胞,但容易复制衰老。 我们还将使用HTERT-RMORMATALIZED人子宫内膜将小鼠的发现转化为人类生物学 基质细胞(T-HESC)作为基质细胞的决策是物理和遗传期间的主要缺陷 老化。结合人与小鼠模型之间的多模式单细胞数据集以及功能 通过CRISPR删除和激活来验证候选候选顺序调节元素和转录共同因素 该建议分别将分别描述PGR动作所需的SIRT1响应性调节网络 这种放松为子宫年龄。我们坚信我们的研究将为更深入,更全面 在生殖衰老期间洞悉耐孕激素子宫内膜。有了新知识,研究 可以采取策略来抵消衰老对妊娠结局的不利影响。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据

数据更新时间:2024-06-01

Xiaoqiu Wang的其他基金

TET2 as a novel epigenetic regulator for uterine function and fertility
TET2 作为子宫功能和生育力的新型表观遗传调节因子
  • 批准号:
    10725828
    10725828
  • 财政年份:
    2023
  • 资助金额:
    $ 56.04万
    $ 56.04万
  • 项目类别:

相似国自然基金

玛纳斯河流域上游吸收性气溶胶来源及其对积雪消融的影响研究
  • 批准号:
    42307523
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
面向肝癌射频消融的智能建模与快速动力学分析方法研究及其临床验证
  • 批准号:
    62372469
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
IRF9调控CD8+T细胞介导微波消融联合TIGIT单抗协同增效抗肿瘤的作用机制
  • 批准号:
    82373219
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
建立可诱导细胞消融系统揭示成纤维细胞在墨西哥钝口螈肢体发育及再生中的作用
  • 批准号:
    32300701
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
肿瘤源PPIA介导结直肠癌肝转移射频消融术残瘤化疗抵抗的机制研究
  • 批准号:
    82302332
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

演繹・帰納融合型統計モデルによる消費者行動のダークマターの解明
使用演绎归纳统计模型阐明消费者行为的暗物质
  • 批准号:
    23K22161
    23K22161
  • 财政年份:
    2024
  • 资助金额:
    $ 56.04万
    $ 56.04万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
    Grant-in-Aid for Scientific Research (B)
Targeted ablation of cerebral atherosclerosis using supramolecular self-assembly
利用超分子自组装靶向消融脑动脉粥样硬化
  • 批准号:
    24K21101
    24K21101
  • 财政年份:
    2024
  • 资助金额:
    $ 56.04万
    $ 56.04万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
    Grant-in-Aid for Early-Career Scientists
心房細動に対するPulsed Field Ablationの組織創傷治癒過程を明らかにする網羅的研究
阐明房颤脉冲场消融组织伤口愈合过程的综合研究
  • 批准号:
    24K11201
    24K11201
  • 财政年份:
    2024
  • 资助金额:
    $ 56.04万
    $ 56.04万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
    Grant-in-Aid for Scientific Research (C)
Examining the Function of a Novel Protein in the Cardiac Junctional Membrane Complex
检查心脏连接膜复合体中新型蛋白质的功能
  • 批准号:
    10749672
    10749672
  • 财政年份:
    2024
  • 资助金额:
    $ 56.04万
    $ 56.04万
  • 项目类别:
遅延造影心臓MRIによる心房細動Ablation冷却効果の比較:28 vs. 31 mm Cryoballoon
使用延迟对比增强心脏 MRI 比较房颤消融冷却效果:28 毫米与 31 毫米 Cryoballoon
  • 批准号:
    24K11281
    24K11281
  • 财政年份:
    2024
  • 资助金额:
    $ 56.04万
    $ 56.04万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
    Grant-in-Aid for Scientific Research (C)